Merck & Co., Inc.

MRK · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $298.8B · 75,000 employees
133
SEC Filings
$115.17
Close 2026-06-01
6
Transcripts
75,000
Employees

Business Summary

Merck & Co., Inc. is a global health care company delivering innovative health solutions through prescription medicines, biologic therapies, vaccines, and animal health products. Key products include Keytruda (pembrolizumab) for oncology, Gardasil 9 for HPV prevention, Winrevair for pulmonary arterial hypertension, Januvia for type 2 diabetes, and a broad animal health portfolio covering livestock and companion animals.

Latest Stock Quote

MRK 2026-06-01 $115.17 O:$117.545 H:$117.96 L:$114.36 Vol:9.4M VWAP:$115.2714
origin leaf: aaaadf74c8bf0d009d3226c94f90257a4655c5c60afdf109eaf38f86a0b81b36

Next Earnings

expected 2026-09-17

Key People

NameRolePeriod
ChristopherAnalyst, Schott JPMorgan Chase & Co? – present
SteveAnalyst Michael Nedelcovych TD Cowen - Analyst, Scala TD Cowen? – present

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMRKdiscussed Artificial Intelligence
topic_mentionMRKdiscussed Blockchain & Crypto
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Cybersecurity
topic_mentionMRKdiscussed Blockchain & Crypto
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Healthcare & Bio
topic_mentionMRKdiscussed Supply Chain
topic_mentionMRKdiscussed Regulation
topic_mentionMRKdiscussed Sovereign & Government
topic_mentionMRKdiscussed Automotive
topic_mentionMRKdiscussed Healthcare & Bio
metricMRK gross marginreported $66.2 percent
metricMRK gross marginreported $74.8 percent
metricMRK gross marginreported $79.7 percent

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310000310158-26-000063EDGAR100K words
2025-02-252024-12-310001628280-25-007732EDGAR—
2024-02-262023-12-310001628280-24-006850EDGAR—
2023-02-242022-12-310001628280-23-005061EDGAR—
2022-02-252021-12-310000310158-22-000003EDGAR—
2021-02-252020-12-310000310158-21-000004EDGAR—
2020-02-262019-12-310000310158-20-000005EDGAR—
2019-02-272018-12-310000310158-19-000014EDGAR—
2018-02-272017-12-310000310158-18-000005EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-05-042026-03-310001628280-26-029802EDGAR—
2025-11-052025-09-300000310158-25-000059EDGAR42K words
2025-08-052025-06-300000310158-25-000014EDGAR—
2025-05-022025-03-310001628280-25-021834EDGAR—
2024-11-062024-09-300001628280-24-045689EDGAR—
2024-08-052024-06-300001628280-24-034715EDGAR—
2024-05-032024-03-310001628280-24-020283EDGAR—
2023-11-032023-09-300001628280-23-036717EDGAR—
2023-08-072023-06-300001628280-23-027770EDGAR—
2023-05-052023-03-310001628280-23-015990EDGAR—
2022-11-032022-09-300000310158-22-000034EDGAR—
2022-08-052022-06-300000310158-22-000030EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-05-280001104659-26-067509EDGAR—
2026-05-220001628280-26-037738EDGAR—
2026-04-300001104659-26-052081EDGAR—
2026-02-030001104659-26-009495EDGAR9K words
2025-12-040001628280-25-055388EDGAR—
2025-10-300001104659-25-103974EDGAR—
2025-09-090000310158-25-000047EDGAR—
2025-07-290001104659-25-071380EDGAR—
2025-05-290001104659-25-054131EDGAR—
2025-04-240001104659-25-038301EDGAR—

133 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— MRK Earnings Call Transcript
— MRK Earnings Call Transcript
— MRK Earnings Call Transcript
— MRK Earnings Call Transcript
— MRK Earnings Call Transcript
— MRK Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology vaccines hospital-acute-care cardiometabolic-and-respiratory virology-/-hiv neuroscience diabetes animal-health---livestock animal-health---companion-animal

Company Identity

CIK0000310158
TickerMRK
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedNJ
Websitehttps://www.merck.com
Listed1949-04-20

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 693d3eabecee93dffb66fd531144d572c058d8b82e9a5a49ab90a5fe61128dba
parent: 665a0eb0079a3a1ad52db0421df625f7707bbdaac91ad6e75fb1636349437180
content hash: 9791c807bcf752e77ca3003140d05d7c16c412ffb69ba30d4c06bac73c6d4ace
signed: 2026-06-02T19:01:56.228Z
sources: 28 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf